Protalix

is an Israel-based biopharmaceutical company that develops and commercializes plant-based proteins for the treatment of fibrosis and inflammatory bowel diseases...
Read more
Protalix President & CEO: Dror Bashan

President & CEO

Dror Bashan

CEO Approval Rating

87/100

Annual Revenue
$53.4M
Employees
200
Funding
$121.8M

Protalix Competitors

1Dyadic
2iBio
3Medicago
4Greenovation
5Crucell
6Icosavax
7MNPHARM
8KBI
9Tedor
10Alvotech

Trending Companies